Scott Fidel
Stock Analyst at Goldman Sachs
(3.89)
# 693
Out of 5,041 analysts
180
Total ratings
91.67%
Success rate
6.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOH Molina Healthcare | Maintains: Neutral | $207 → $167 | $163.32 | +2.25% | 11 | Oct 24, 2025 | |
| ARDT Ardent Health | Initiates: Neutral | $19 | $15.21 | +24.92% | 6 | Oct 14, 2025 | |
| UHS Universal Health Services | Assumes: Neutral | $219 | $210.68 | +3.95% | 11 | Oct 14, 2025 | |
| THC Tenet Healthcare | Assumes: Buy | $224 | $210.38 | +6.47% | 11 | Oct 14, 2025 | |
| HCA HCA Healthcare | Assumes: Buy | $470 | $447.04 | +5.14% | 10 | Oct 14, 2025 | |
| OSCR Oscar Health | Initiates: Neutral | $17 | $19.29 | -11.87% | 1 | Oct 14, 2025 | |
| ELV Elevance Health | Initiates: Neutral | $343 | $342.35 | +0.19% | 4 | Oct 14, 2025 | |
| CNC Centene | Initiates: Sell | $33 | $34.07 | -3.14% | 10 | Oct 14, 2025 | |
| ALHC Alignment Healthcare | Initiates: Buy | $21 | $17.51 | +19.93% | 6 | Oct 14, 2025 | |
| CVS CVS Health | Initiates: Buy | $91 | $81.93 | +11.07% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $370 | $301.78 | +22.61% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $406 | $362.50 | +12.00% | 23 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $142 | $121.63 | +16.75% | 12 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $38 | $25.24 | +50.55% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $48 → $31 | $12.66 | +144.87% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $186.05 | -10.24% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $28.53 | -26.39% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $290.65 | -13.99% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $126.13 | -16.75% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $23.39 | +293.41% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $9.43 | -84.09% | 3 | Nov 11, 2022 |
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $207 → $167
Current: $163.32
Upside: +2.25%
Ardent Health
Oct 14, 2025
Initiates: Neutral
Price Target: $19
Current: $15.21
Upside: +24.92%
Universal Health Services
Oct 14, 2025
Assumes: Neutral
Price Target: $219
Current: $210.68
Upside: +3.95%
Tenet Healthcare
Oct 14, 2025
Assumes: Buy
Price Target: $224
Current: $210.38
Upside: +6.47%
HCA Healthcare
Oct 14, 2025
Assumes: Buy
Price Target: $470
Current: $447.04
Upside: +5.14%
Oscar Health
Oct 14, 2025
Initiates: Neutral
Price Target: $17
Current: $19.29
Upside: -11.87%
Elevance Health
Oct 14, 2025
Initiates: Neutral
Price Target: $343
Current: $342.35
Upside: +0.19%
Centene
Oct 14, 2025
Initiates: Sell
Price Target: $33
Current: $34.07
Upside: -3.14%
Alignment Healthcare
Oct 14, 2025
Initiates: Buy
Price Target: $21
Current: $17.51
Upside: +19.93%
CVS Health
Oct 14, 2025
Initiates: Buy
Price Target: $91
Current: $81.93
Upside: +11.07%
Oct 14, 2025
Initiates: Buy
Price Target: $370
Current: $301.78
Upside: +22.61%
Oct 14, 2025
Initiates: Buy
Price Target: $406
Current: $362.50
Upside: +12.00%
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $121.63
Upside: +16.75%
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $25.24
Upside: +50.55%
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $12.66
Upside: +144.87%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $186.05
Upside: -10.24%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $28.53
Upside: -26.39%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $290.65
Upside: -13.99%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $126.13
Upside: -16.75%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $23.39
Upside: +293.41%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $9.43
Upside: -84.09%